识别儿童白血病复发的危险因素使用惩罚性半参数混合物治疗竞争风险模型
Zahra Mehrbakhsh1,2, Leili Tapak1,3, Nasser Behnampour4
1Department of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
Journal of research in health sciences
|July 29, 2024
概括
这项研究使用惩罚性混合疗法模型确定了儿童白血病复发和死亡的关键预后因素. 血小板计数,白血病类型,中瘤和脊髓巨变会影响复发,而白细胞计数和类风湿性关节炎症状会影响生存率.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 生物统计学 生物统计学
背景情况:
- 儿童白血病是一个重大的健康问题,需要改进预后因素的识别.
- 鉴定预后因素的传统统计方法可能不足.
- 可靠的模型对于预测小儿白血病患者的生存和复发至关重要.
研究的目的:
- 应用一个惩罚性的半参数混合疗法模型来分析儿童白血病.
- 确定影响儿科白血病短期和长期生存的预后因素.
- 在竞争性风险框架内调查影响儿童白血病复发时间的因素.
主要方法:
- 对178名儿科白血病患者 (0-15岁) 的回顾性队列研究.
- 1997年9月至2021年6月在伊朗戈勒斯坦医学科学大学收集的数据.
- 分析采用了受惩罚的半参数混合疗法,与SCAD和LASSO调整相竞争的风险模型.
主要成果:
- 血小板计数,白血病类型 (ALL vs. AML),中瘤的存在和大是复发的显著预测因素.
- 白细胞计数和类风湿性关节炎症状的存在是死亡的重要预测因素.
- SCAD规范化有效地确定了模型的治疗和延迟部分的关键预后因素.
结论:
- 实验室发现和临床因素与儿童白血病的复发和死亡率有关.
- 这些已识别的因素可以帮助制定治疗策略和预测结果.
- 这项研究强调了先进的统计模型在儿科瘤学研究中的有用性.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
168
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
168
Kaplan-Meier Approach
117
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
117
Cancer Survival Analysis
336
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
336
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Statistical Methods for Analyzing Epidemiological Data
342
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
342
Relative Risk
139
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
139


